Multiple Sclerosis News Today | Symptoms, Diagnosis, Treatments
November 6, 2024 News by Marisa Wexler, MS. Scientists create platform for devices that wrap around nerve fibers. A new technology is designed to be a “wearable” device for neurons, …
Treatment of progressive MS hits milestones in recent years: Study
August 14, 2024 News by Esteban Domínguez Cerezo, MS. Phase 1 trial to begin of CAR T-cell therapy azer-cel for progressive MS. July 12, 2024 News by Katherine Poinsatte, PhD.
MRI analysis of MS ReBUILD data shows remyelination with...
Jun 16, 2023 · October 8, 2024 News by Esteban Domínguez Cerezo, MS. Nerve stimulator for myelin repair to enter RRMS clinical trial. March 6, 2024 News by Marisa Wexler, MS.
The MS News Today Podcast - Multiple Sclerosis News Today
Jenn is the Brand and Marketing Manager for Bionews (Multiple Sclerosis News Today is a subsidiary of Bionews). Jenn is also the host of the Multiple Sclerosis Podcast as well as a …
1-year fenebrutinib inhibits nearly all MS signs in relapsing MS trial
Sep 6, 2024 · The Phase 2 FENopta trial (NCT05119569) evaluated fenebrutinib’s safety and efficacy in 109 adults, ages 18-55, with relapsing forms of MS, including relapsing-remitting …
Top 10 Multiple Sclerosis Stories of 2021
Jan 3, 2022 · We look forward to continuing to be a resource for the MS community in 2022. Here are the Top 10 most-read articles of 2021, with a brief description of what made them relevant …
MS news notes: Vaccines, migraines, eye-tracking technology
Sep 18, 2023 · The MS News Today story “ No greater risk of hospitalization found after vaccines in MS in study ” reports on a nationwide study in France involving over 100,000 people, that …
Top 10 MS stories of 2023 - Multiple Sclerosis News Today
News; Top 10 MS stories of 2023 Top 10 MS stories of 2023. Of most interest to readers was news on potential treatments, triggers. by Marisa Wexler, MS | January 2, 2024.
MS news notes: Vumerity, herpes virus, caregivers
Nov 27, 2023 · In the study, Vumerity, an approved oral disease-modifying therapy, significantly reduced relapse rates by more than 80% over a two-year period. Also, the number of actively …
MS news notes: Stem cell therapy, early Aubagio use, DMTs
May 1, 2023 · Several years ago, MS News Today reported that researchers disagreed at the time about whether to start any treatment for people with RIS. New data from a Phase 3 …